z-logo
open-access-imgOpen Access
In Pilot Study, Radioiodine-Refractory Thyroid Cancer Shown as Responsive to Dabrafenib
Author(s) -
Mark Fuerst
Publication year - 2013
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000440860.10659.e8
Subject(s) - dabrafenib , medicine , thyroid cancer , thyroid carcinoma , papillary thyroid cancer , trametinib , thyroid , cancer research , cancer , oncology , mek inhibitor , mapk/erk pathway , kinase , biology , vemurafenib , metastatic melanoma , microbiology and biotechnology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here